Trial intelligence / Profile preview

Pudafensine Phase II Study in Erectile Dysfunction

NCT04969666Phase 2Unknown

Sponsor
Initiator Pharma A/S
Start
Aug 2021
Primary completion
Sep 2022
Modality
Small Molecules
01

Overview

A Phase 2 trial of pudafensine in erectile dysfunction (ED), sponsored by Initiator Pharma A/S. Status: unknown.

02

Drugs

pudafensine
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT04969666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04969666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call